TBA Law Blog


Posted by: Stacey Shrader Joslin on Aug 16, 2023

The abortion pill mifepristone will remain available to patients but with restrictions, a three judge panel of the U.S. 5th Circuit Court of Appeals ruled today. By a vote of 3-0, the panel blocked changes made by the Food and Drug Administration in 2016 to make the drug more accessible, but noted that its decision is subject to a prior U.S. Supreme Court order, which “stayed the district court’s order pending resolution of this appeal.” In addition, it ruled 2-1 to overturn a lower court ruling that suspended overall approval of the drug. Read more from Reuters or read the ruling.